Image courtesy of VuComp Inc.
March 17, 2015 — VuComp Inc. announced that it has received U.S. Food and Drug Administration (FDA) approval for M-Vu CAD (computer-aided detection) for mammography version 3.2. This latest version of the M-Vu CAD algorithm provides an increase in sensitivity, resulting in an improvement in mass detection performance.
The M-Vu CAD system was designed as a mammography CAD product to meet the rigorous FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.
In addition to M-Vu CAD, VuComp has developed and commercialized M-Vu Breast Density which received FDA market clearance in December 2013.
For more information: www.vucomp.com
April 20, 2026 
